In contrast, PTEN is underexpressed by BCR-ABL which facilitated CML progression, while overexpressed PTEN postponed disease progression by inhibiting LSC function. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.